Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT00489905
Eligibility Criteria:
Inclusion Criteria:
* Prostate cancer patients aged between 50-80 who is having or will have ADT. Baseline BMD in between -2 standard deviation (SD) and mean of that among young adults.
Exclusion Criteria:
* Patients with renal or liver problems, on calcium or other bisphosphonate therapy within six months before enrolling into the study.
Patients who have:
* Serum creatinine levels \>212 µmol/L (2.4 mg/dL).
* Creatinine clearance \<50 ml/min.
* WBC \<4.0x109/L, Hgb \<10 g/dL, platelets \<140x109/L. Patients with known hypersensitivity to bisphosphonates. Patients with history of diseases with influence on bone metabolism, such as Page's disease of bone, primary hyperparathyroidism or osteoporosis.
Sex:
MALE
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT00489905
Study Brief:
Protocol Section:
NCT00489905